Investigators from the STOP-NIDDM trial wereinterested in whether PPAR polymorphisms would be associated with theconversion to type 2 DM in response to acarbose in patients with impairedglucose tolerance [72, 73]. This evidence concerns the gene PPARA and type 2 diabetes mellitus.